Search

Your search keyword '"Y. Baranau"' showing total 8 results
Start Over Author "Y. Baranau" Topic business
8 results on '"Y. Baranau"'

1. 759P Adding dosing of plasmid encoding p62/SQSTM1 to gemcitabine chemotherapy may provide clinical benefits to patients with platinum-resistant ovarian cancer

Author

A. Khorau, E. Zhavrid, O. Sergeeva, S. Kozlovskaya, S. Polyakov, A. Shneider, K. Zharkova, V. Gabai, Y. Baranau, and S. Krasny

Subjects
Chemotherapy, business.industry, medicine.medical_treatment, Hematology, medicine.disease, Gemcitabine, Plasmid, Oncology, Cancer research, Medicine, Dosing, business, Ovarian cancer, Platinum resistant, medicine.drug
Published
2021
Full Text
View/download PDF

2. LBA27 Erdafitinib (ERDA) or ERDA plus cetrelimab (CET) for patients with metastatic or locally advanced urothelial carcinoma (mUC) and Fibroblast Growth Factor Receptor alterations (FGFRa): First phase (Ph) II results from the NORSE study

Author

A. Santiago-Walker, G. Del Conte, E. Everaert, M. Hosseini, Yann-Alexandre Vano, M. Tammaro, Virtudes Moreno, B. Perez Valderrama, Arlene O. Siefker-Radtke, Anne OHagan, V. Chistyakov, T.W. Kang, H. Chhabra, Thomas Powles, Y. Baranau, S. Triantos, Y. Loriot, A. Semenov, and V. Beliakouski

Subjects
Oncology, Erdafitinib, Fibroblast growth factor receptor, business.industry, Locally advanced, Cancer research, Medicine, Hematology, business, Urothelial carcinoma
Published
2021
Full Text
View/download PDF

3. 278P Plasmid encoding p62/SQSTM1 administered in combination with CMF chemotherapy improves outcomes in metastatic triple-negative breast cancer patients

Author

A. Shneider, A. Khorau, S. Krasny, O. Sergeeva, Y. Baranau, S. Kozlovskaya, S. Polyakov, K. Zharkova, E. Zhavrid, V. Gabai, and A.A. Sufianov

Subjects
Oncology, medicine.medical_specialty, Chemotherapy, Plasmid, business.industry, Internal medicine, medicine.medical_treatment, medicine, Hematology, business, Triple-negative breast cancer
Published
2021
Full Text
View/download PDF

6. 8041 Preliminary results of whole-body hyperthermia in combination with oxaliplatin in patients with platinum-resistant/refractory ovarian cancer

Author

E. Zhavrid, Y.U. Istomin, A. Mazurenko, E. Alexandrova, V. Siarheyeva, I. Zhuravkin, Y. Baranau, and S. Petrovitch

Subjects
Oncology, Hyperthermia, Cancer Research, medicine.medical_specialty, business.industry, medicine.disease, Oxaliplatin, Refractory, Internal medicine, medicine, In patient, Whole body, Ovarian cancer, business, medicine.drug, Platinum resistant
Published
2009
Full Text
View/download PDF

7. 9338 Experience in administration of high-dose interleukin-2 immunotherapy in combination with chemotherapy for disseminated skin melanoma management

Author

S. Petrovitch, Y. Baranau, N. Sachivko, E. Zhavrid, and I. Zhuravkin

Subjects
Oncology, Interleukin 2, Cancer Research, Chemotherapy, medicine.medical_specialty, business.industry, medicine.medical_treatment, Immunotherapy, Internal medicine, medicine, Skin melanoma, business, Administration (government), medicine.drug
Published
2009
Full Text
View/download PDF

8. 9428 Experience in high-dose chemotherapy with peripheral stem cell rescue and biotherapy for young adults with high-risk Ewing/PNET sarcoma

Author

O. Aleinikova, E. Demidovich, I. Minailo, Y. Baranau, M. Belotserkovskaya, Y.U. Strongin, L. Kiselev, E. Zhavrid, N. Stuk, and S. Petrovitch

Subjects
Cancer Research, High dose chemotherapy, Pathology, medicine.medical_specialty, Oncology, Stem cell rescue, business.industry, Medicine, Sarcoma, Young adult, business, medicine.disease, Peripheral
Published
2009
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results